Vireo Growth (VREOF) Assets (2020 - 2026)
Vireo Growth (VREOF) reported Assets of $928.8 million for Q1 2026, up 235.25% on a YoY basis from $277.0 million in Q1 2025, and up 13.66% sequentially from $817.2 million in Q4 2025.
Vireo Growth (VREOF) Assets (2020 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 7 years of Assets data on file, last reported at $928.8 million in Q1 2026.
- For the quarter ending Q1 2026, Assets rose 235.25% year-over-year to $928.8 million; the trailing twelve-month figure through Mar 2026 stood at $928.8 million (up 235.25% YoY), and the FY2025 full-year result was $817.2 million, up 193.05% from the prior year.
- Assets rose to $928.8 million in Q1 2026, from $817.2 million in the prior quarter.
- In the past five years, Assets ranged from a high of $928.8 million in Q1 2026 to a low of $158.6 million in Q1 2023.
- A 5-year average of $327.1 million and a median of $190.9 million in 2024 frame the typical range for Assets.
- Across the five-year window, Assets dropped 4.68% in 2022 and jumped 250.19% in 2025, its largest moves.
- Tracing VREOF's Assets over 5 years: stood at $159.2 million in 2022, then advanced by 15.15% to $183.3 million in 2023, then jumped by 52.16% to $278.9 million in 2024, then surged by 193.05% to $817.2 million in 2025, then gained by 13.66% to $928.8 million in 2026.
- Business Quant data shows VREOF's Assets at $928.8 million in Q1 2026, $817.2 million in Q4 2025, and $678.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 928.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 928.80 Mn |
| Dec 31, 2025 | 817.20 Mn |
| Sep 30, 2025 | 678.92 Mn |
| Jun 30, 2025 | 659.34 Mn |
| Mar 31, 2025 | 277.05 Mn |
| Dec 31, 2024 | 278.86 Mn |
| Sep 30, 2024 | 193.87 Mn |
| Jun 30, 2024 | 194.68 Mn |
| Mar 31, 2024 | 190.88 Mn |
| Dec 31, 2023 | 183.26 Mn |
| Sep 30, 2023 | 171.67 Mn |
| Jun 30, 2023 | 165.95 Mn |
| Mar 31, 2023 | 158.63 Mn |
| Dec 31, 2022 | 159.16 Mn |
| Sep 30, 2022 | 173.32 Mn |
| Jun 30, 2022 | 168.82 Mn |
| Mar 31, 2022 | 160.73 Mn |
| Dec 31, 2021 | 166.97 Mn |
| Sep 30, 2021 | 164.16 Mn |
| Jun 30, 2021 | 112.68 Mn |